MSD
The Principal Scientist, Early DCT Lead provides strategic, technical, and operational direction for integrated CMC teams, advancing a portfolio of pipeline biologics from candidate selection through early clinical development and First-in-Human milestones. This role involves leading matrixed teams, driving cross-functional alignment, and supporting drug product activities to ensure robust formulation and manufacturing strategies. The position requires bridging enterprise matrix leadership with rigorous technical acumen to manage program risk and champion scientific excellence.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago